Platelet Inhibition by Abciximab Bolus-Only Administration and Oral ADP Receptor Antagonist Loading in Acute Coronary Syndrome Patients: The Blocking and Bridging Strategy-Reference-Cited by-同舟云学术

Platelet Inhibition by Abciximab Bolus-Only Administration and Oral ADP Receptor Antagonist Loading in Acute Coronary Syndrome Patients: The Blocking and Bridging Strategy

Published:2013-07 Issue:1 Volume:132 Page:e36-e41
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Christ Günter,Hafner Thomas,Siller-Matula Jolanta M.,Francesconi Marcel,Grohs Katharina,Wilhelm Eva,Podczeck-Schweighofer Andrea

Publisher

Elsevier BV

Subject

Hematology

Reference24 articles.

1. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology;Steg;Eur Heart J,2012

2. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

3. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation;N Engl J Med,1994

4. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial;Marmur;Am Heart J,2006

5. Prasugrel versus clopidogrel in patients with acute coronary syndromes;Wiviott;N Engl J Med,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?;Journal of Clinical Medicine;2022-12-04

2. Intracoronary bolus of glycoprotein IIb/IIIa inhibitor as bridging or adjunctive strategy to oral P2Y12 inhibitor load in the modern setting of STEMI;Minerva Cardiology and Angiology;2021-04

3. Prasugrel or ticagrelor relative to clopidogrel in triple-antiplatelet treatment combined with glycoprotein IIb/IIIa inhibitor for patients with STEMI undergoing PCI: a meta-analysis;BMC Cardiovascular Disorders;2020-03-12

4. Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?;Journal of Clinical Medicine;2019-12-07

5. Atrial Fibrillation on Vitamin K Antagonist Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Elevation Myocardial Infarction;Atrial Fibrillation and Percutaneous Coronary Intervention;2016-12-02